MedTech News
.................... by Andrew Celentano
New transparent ‘blood vessel-on-a-chip’ could reduce animal testing
Researchers have developed a “blood vessel-on-a-chip” for heart disease with the potential to change the future of drug testing and development. The technology could also reduce our reliance on animal testing.
Detachable cardiac pacing lead may improve safety for cardiac patients
The minimally invasive, 3d-printable device offers safer application and removal, along with improved bioelectronic performance.
A prosthesis driven by the nervous system helps people with amputation walk naturally
A new surgical procedure gives people more neural feedback from their residual limb. With it, seven patients walked more naturally and navigated obstacles.
Rady Children’s announces launch of new no-cost 3D model viewing technology
Developed using Unity, the software allows viewing of advanced 3D reconstructions directly on a surgeon’s computer.
FDA clears IceCure Medical’s next-gen single-probe cryoablation system
IceCure Medical (Nasdaq:ICCM) announced today that the FDA granted clearance for its next-generation single-probe cryoablation system
CeQur wins FDA nod for mealtime insulin delivery device
Each patch now replaces up to 12 mealtime injections, equaling more than 1,000 fewer injections annually, according to a news release.
Researchers develop an alternative to pacemakers in the form of a hydrogel
A heart attack is a life-threatening condition, with patients remaining at risk of premature death long after the actual attack—50% to 60% of patients die subsequently as a result of sudden cardiac death, triggered by cardiac arrhythmia.
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
SILVER SPRING, Md., June 27, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress System, the first hepatitis C virus (HCV) test that can be used to bring diagnosis to appropriately certified point-of-care settings for individuals at risk for hepatitis C.